Sekhmet Pharmaventures Appoints Jitendra Jalan as CHRO

PAG-led Sekhmet Pharmaventures has appointed Jitendra Jalan as Chief Human Resources Officer (CHRO).

Alongside the CHRO appointment, Sekhmet has also named Sumit Kumar as Chief Commercial Officer, further reinforcing its leadership bench across commercial and people functions.

In this new role, as CHRO, Jalan will lead the company’s global people strategy, focusing on leadership development, strategic HR business partnering, and fostering a people-centric culture to support sustained growth.

Sekhmet has seen strong business momentum in FY26 under its new leadership, driven by deeper integration of its API and CDMO capabilities. The company has recorded over 25% EBITDA growth in the first eight months of FY26, reflecting improved customer confidence and operational performance.

Extensive Experience

Jalan brings over 25 years of multidisciplinary leadership experience spanning Sales, Operations, and Human Resources.

He has held senior leadership roles at organisations including USV Pvt Ltd, ACC Ltd, Endress+Hauser India and Astral Glass, and is widely recognised for leading large-scale organisational transformations and strengthening leadership pipelines in complex, multi-location environments.

He holds a PGCHRM from XLRI, is SHRM-SCP certified, and an ICF-ACC accredited executive coach.

At Sekhmet, Jalan will work closely with business leaders to align talent, culture and capability with the company’s global growth ambitions, while strengthening succession planning and organisational effectiveness.

Commenting on the appointment, Santosh Mahil, Managing Director & CEO, Sekhmet, said that Jalan’s appointment strengthens the company’s organisational leadership as it scales its API and CDMO businesses globally.

About the Company

Sekhmet operates six manufacturing facilities through Optimus Drugs and Anjan Drug, offering integrated API and CDMO capabilities with strong expertise in complex and green chemistry.

PAG is a leading Asia-focused investment firm managing over USD 55 billion across private equity, credit, and real assets.

Note: We are also on WhatsApp, LinkedIn, and YouTube to get the latest news updates. Subscribe to our Channels. WhatsApp– Click Here, YouTube – Click Here, and LinkedIn– Click Here.